ClinVar Genomic variation as it relates to human health
NM_021625.5(TRPV4):c.943C>T (p.Arg315Trp)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_021625.5(TRPV4):c.943C>T (p.Arg315Trp)
Variation ID: 4999 Accession: VCV000004999.26
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 12q24.11 12: 109798823 (GRCh38) [ NCBI UCSC ] 12: 110236628 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 5, 2015 Oct 8, 2024 Jan 24, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_021625.5:c.943C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_067638.3:p.Arg315Trp missense NM_001177428.1:c.802C>T NP_001170899.1:p.Arg268Trp missense NM_001177431.1:c.841C>T NP_001170902.1:p.Arg281Trp missense NM_001177433.1:c.802C>T NP_001170904.1:p.Arg268Trp missense NM_147204.2:c.943C>T NP_671737.1:p.Arg315Trp missense NC_000012.12:g.109798823G>A NC_000012.11:g.110236628G>A NG_017090.1:g.39585C>T LRG_372:g.39585C>T LRG_372t1:c.943C>T LRG_372p1:p.Arg315Trp Q9HBA0:p.Arg315Trp - Protein change
- R315W, R281W, R268W
- Other names
- -
- Canonical SPDI
- NC_000012.12:109798822:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TRPV4 | - | - |
GRCh38 GRCh37 |
1137 | 1152 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely pathogenic (2) |
criteria provided, single submitter
|
Mar 31, 2020 | RCV000005290.14 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Jan 24, 2024 | RCV000005291.24 | |
Pathogenic (1) |
no assertion criteria provided
|
Dec 1, 2011 | RCV000005289.13 | |
not provided (1) |
no classification provided
|
- | RCV000202514.10 | |
Uncertain significance (1) |
no assertion criteria provided
|
- | RCV000789585.9 | |
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Nov 29, 2023 | RCV000236487.18 | |
TRPV4-Associated Disorders
|
Pathogenic (1) |
criteria provided, single submitter
|
- | RCV003335013.1 |
Pathogenic (1) |
criteria provided, single submitter
|
Nov 4, 2022 | RCV002371762.9 | |
TRPV4-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Jan 12, 2024 | RCV004547459.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Mar 31, 2020)
|
criteria provided, single submitter
Method: research
|
Scapuloperoneal spinal muscular atrophy
Affected status: yes
Allele origin:
germline
|
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, Koc University
Accession: SCV001251010.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Number of individuals with the variant: 5
Geographic origin: Anatolian Peninsula
|
|
Pathogenic
(Nov 04, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Inborn genetic diseases
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002684632.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The c.943C>T (p.R315W) alteration is located in exon 6 (coding exon 5) of the TRPV4 gene. This alteration results from a C to T substitution … (more)
The c.943C>T (p.R315W) alteration is located in exon 6 (coding exon 5) of the TRPV4 gene. This alteration results from a C to T substitution at nucleotide position 943, causing the arginine (R) at amino acid position 315 to be replaced by a tryptophan (W). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been detected as de novo in an individual with Kozslowski type spondylometaphyseal dysplasia and Charcot-Marie-Tooth disease type 2C (CMT2C) (Faye, 2019). It has also been found to segregate with TRPV4-related disorders such as congenital distal spinal muscular atrophy (CDSMA), scapuloperoneal spinal muscular atrophy (SPSMA), and hereditary motor and sensory neuropathy type IIc (HMSN2C) in multiple families (Chen, 2010; Auer-Grumbach, 2010). This alteration has been described in additional unrelated individuals with TRPV4-related disorders (Tunca, 2020; Velilla, 2019; Aharoni, 2011; Echaniz-Laguna, 2014). Based on the available evidence, this alteration is classified as pathogenic. (less)
|
|
Pathogenic
(Oct 17, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics Laboratory, Skane University Hospital Lund
Accession: SCV005198881.1
First in ClinVar: Aug 25, 2024 Last updated: Aug 25, 2024 |
|
|
Pathogenic
(Jun 24, 2013)
|
criteria provided, single submitter
Method: clinical testing
|
Charcot-Marie-Tooth disease type 2C
(Autosomal dominant inheritance)
Affected status: unknown
Allele origin:
germline
|
Athena Diagnostics
Accession: SCV000255847.2
First in ClinVar: Oct 19, 2015 Last updated: Oct 19, 2015 |
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
TRPV4-associated disorders
Affected status: yes
Allele origin:
germline
|
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
Accession: SCV004046321.1
First in ClinVar: Oct 21, 2023 Last updated: Oct 21, 2023 |
Comment:
This variant has been previously reported as a heterozygous change in families with hereditary motor and sensory neuropathy type 2C, scapuloperoneal spinal muscular atrophy, Charcot-Marie-Tooth … (more)
This variant has been previously reported as a heterozygous change in families with hereditary motor and sensory neuropathy type 2C, scapuloperoneal spinal muscular atrophy, Charcot-Marie-Tooth Type 2C (CMT2C) with vocal cord paresis and congenital distal SMA (PMID: 20037588, 21115951, 20460441, 22065612). Functional studies show that this variant alters the localization of the TRPV4 protein to the cell surface and increases the basal calcium levels leading to increased cell death (PMID: 20037588, 22702953, 21454511). The c.943C>T (p.Arg315Trp) variant is absent from the gnomAD population database and thus is presumed to be rare. It affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.943C>T (p.Arg315Trp) variant is classified as Pathogenic. (less)
|
|
Pathogenic
(Jan 24, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Charcot-Marie-Tooth disease axonal type 2C
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000646256.6
First in ClinVar: Dec 26, 2017 Last updated: Feb 20, 2024 |
Comment:
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 315 of the TRPV4 protein … (more)
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 315 of the TRPV4 protein (p.Arg315Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with hereditary motor and sensory neuropathy type 2C (HMSN2C), scapuloperoneal spinal muscular atrophy (SPSMA), Charcot-Marie-Tooth Type 2C (CMT2C) with vocal cord paresis, and congenital distal SMA (PMID: 20037588, 20460441, 21115951, 22065612). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4999). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TRPV4 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects TRPV4 function (PMID: 20037588, 21454511, 22702953). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Nov 29, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000292701.13
First in ClinVar: Jul 24, 2016 Last updated: Sep 16, 2024 |
Comment:
Published functional studies suggest significant disruption of TRPV4-RhoA interaction as well as suppressed interaction of wild-type TRPV4 with RhoA (PMID: 33664271); In silico analysis supports … (more)
Published functional studies suggest significant disruption of TRPV4-RhoA interaction as well as suppressed interaction of wild-type TRPV4 with RhoA (PMID: 33664271); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21115951, 21454511, 22702953, 31191204, 31041394, 24830047, 32579787, 34426522, 32481620, 35032046, 35170874, 36118854, 37706131, 20037588, 33664271) (less)
|
|
Uncertain significance
(-)
|
no assertion criteria provided
Method: literature only
|
Autosomal dominant distal hereditary motor neuropathy
Affected status: yes
Allele origin:
germline
|
Inherited Neuropathy Consortium
Accession: SCV000928941.1
First in ClinVar: Jul 27, 2019 Last updated: Jul 27, 2019 |
|
|
Likely pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV002036923.1 First in ClinVar: Dec 18, 2021 Last updated: Dec 18, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV002037334.1 First in ClinVar: Dec 18, 2021 Last updated: Dec 18, 2021 |
|
|
Pathogenic
(Dec 01, 2011)
|
no assertion criteria provided
Method: literature only
|
NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 8
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000025467.4
First in ClinVar: Apr 04, 2013 Last updated: Oct 21, 2023 |
Comment on evidence:
Auer-Grumbach et al. (2010) reported a large 5-generation family in which 10 individuals with a neuromuscular disease carried the same heterozygous c.943C-T transition in exon … (more)
Auer-Grumbach et al. (2010) reported a large 5-generation family in which 10 individuals with a neuromuscular disease carried the same heterozygous c.943C-T transition in exon 6 of the TRPV4 gene, resulting in an arg315-to-trp (R315W) substitution. Four patients had hereditary motor and sensory neuropathy type IIC (HMSN2C; 606071), 1 had distal hereditary motor neuropathy, type VIII (HMND8; 600175), and 2 had scapuloperoneal spinal muscular atrophy (SPSMA; 181405). Inheritance was autosomal dominant. The R315W mutation was also identified in an unrelated family in which 6 members had HMSN2C (McEntagart et al., 2005). The mutation was not found in 304 control individuals. The R315W mutation occurred at the outer helices of the ANK4 and ANK5 domains in the N-terminal cytoplasmic domain. In vitro functional expression studies in HeLa cells showed that the mutant protein formed cytoplasmic aggregates and had reduced surface expression. In cotransfection studies, both mutant and wildtype proteins were detected in cytoplasmic aggregates. Mutant TRPV4 cells showed an impaired response to stimulus-dependent channel activity. The studies indicated that the mutation interferes with normal channel trafficking and function. Haploinsufficiency was proposed as the most likely underlying mechanism, although a gain of function could not be fully excluded. Chen et al. (2010) identified a heterozygous R315W mutation in a 47-year-old mother and her 26-year-old daughter with HMSN2C and vocal cord paresis; the family had originally been reported by Dyck et al. (1994). Both patients had onset in infancy and developed a relatively severe form of distal muscle weakness and distal sensory loss, as well as short stature. Aharoni et al. (2011) reported a 3-generation family of Ashkenazi/Sephardic Jewish origin with variable expression of HMSN2C due to a heterozygous R315W TRPV4 mutation. Five mutation carriers in 1 family were studied. The proband was a girl who presented at birth with inspiratory stridor, clubfeet, congenital hip dislocation, and knee contractures. She had absent reflexes and bilateral vocal cord paresis requiring tracheostomy. In childhood, she showed delayed motor development, progressive distal amyotrophy and weakness, weakness of the shoulder girdle, scoliosis, and pectus excavatum. Neurophysiologic studies showed an axonal sensorimotor neuropathy. Two of her affected brothers also presented with stridor in infancy and showed a similar phenotype, but without electrophysiologic examination. The mother showed a milder phenotype; she reported being unathletic as a child and having a hoarse voice. In her thirties, she developed slowly progressive fatigue associated with mild distal muscle atrophy in the lower limbs. She had poor reflexes and minimal distal temperature sensitivity. Electrophysiologic studies showed a sensorimotor neuropathy. One mutation carrier in this family was clinically unaffected at age 14 years, although deep tendon reflexes were difficult to elicit. (less)
|
|
Pathogenic
(Dec 01, 2011)
|
no assertion criteria provided
Method: literature only
|
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000025468.4
First in ClinVar: Apr 04, 2013 Last updated: Oct 21, 2023 |
Comment on evidence:
Auer-Grumbach et al. (2010) reported a large 5-generation family in which 10 individuals with a neuromuscular disease carried the same heterozygous c.943C-T transition in exon … (more)
Auer-Grumbach et al. (2010) reported a large 5-generation family in which 10 individuals with a neuromuscular disease carried the same heterozygous c.943C-T transition in exon 6 of the TRPV4 gene, resulting in an arg315-to-trp (R315W) substitution. Four patients had hereditary motor and sensory neuropathy type IIC (HMSN2C; 606071), 1 had distal hereditary motor neuropathy, type VIII (HMND8; 600175), and 2 had scapuloperoneal spinal muscular atrophy (SPSMA; 181405). Inheritance was autosomal dominant. The R315W mutation was also identified in an unrelated family in which 6 members had HMSN2C (McEntagart et al., 2005). The mutation was not found in 304 control individuals. The R315W mutation occurred at the outer helices of the ANK4 and ANK5 domains in the N-terminal cytoplasmic domain. In vitro functional expression studies in HeLa cells showed that the mutant protein formed cytoplasmic aggregates and had reduced surface expression. In cotransfection studies, both mutant and wildtype proteins were detected in cytoplasmic aggregates. Mutant TRPV4 cells showed an impaired response to stimulus-dependent channel activity. The studies indicated that the mutation interferes with normal channel trafficking and function. Haploinsufficiency was proposed as the most likely underlying mechanism, although a gain of function could not be fully excluded. Chen et al. (2010) identified a heterozygous R315W mutation in a 47-year-old mother and her 26-year-old daughter with HMSN2C and vocal cord paresis; the family had originally been reported by Dyck et al. (1994). Both patients had onset in infancy and developed a relatively severe form of distal muscle weakness and distal sensory loss, as well as short stature. Aharoni et al. (2011) reported a 3-generation family of Ashkenazi/Sephardic Jewish origin with variable expression of HMSN2C due to a heterozygous R315W TRPV4 mutation. Five mutation carriers in 1 family were studied. The proband was a girl who presented at birth with inspiratory stridor, clubfeet, congenital hip dislocation, and knee contractures. She had absent reflexes and bilateral vocal cord paresis requiring tracheostomy. In childhood, she showed delayed motor development, progressive distal amyotrophy and weakness, weakness of the shoulder girdle, scoliosis, and pectus excavatum. Neurophysiologic studies showed an axonal sensorimotor neuropathy. Two of her affected brothers also presented with stridor in infancy and showed a similar phenotype, but without electrophysiologic examination. The mother showed a milder phenotype; she reported being unathletic as a child and having a hoarse voice. In her thirties, she developed slowly progressive fatigue associated with mild distal muscle atrophy in the lower limbs. She had poor reflexes and minimal distal temperature sensitivity. Electrophysiologic studies showed a sensorimotor neuropathy. One mutation carrier in this family was clinically unaffected at age 14 years, although deep tendon reflexes were difficult to elicit. (less)
|
|
Pathogenic
(Dec 01, 2011)
|
no assertion criteria provided
Method: literature only
|
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000025469.4
First in ClinVar: Apr 04, 2013 Last updated: Oct 21, 2023 |
Comment on evidence:
Auer-Grumbach et al. (2010) reported a large 5-generation family in which 10 individuals with a neuromuscular disease carried the same heterozygous c.943C-T transition in exon … (more)
Auer-Grumbach et al. (2010) reported a large 5-generation family in which 10 individuals with a neuromuscular disease carried the same heterozygous c.943C-T transition in exon 6 of the TRPV4 gene, resulting in an arg315-to-trp (R315W) substitution. Four patients had hereditary motor and sensory neuropathy type IIC (HMSN2C; 606071), 1 had distal hereditary motor neuropathy, type VIII (HMND8; 600175), and 2 had scapuloperoneal spinal muscular atrophy (SPSMA; 181405). Inheritance was autosomal dominant. The R315W mutation was also identified in an unrelated family in which 6 members had HMSN2C (McEntagart et al., 2005). The mutation was not found in 304 control individuals. The R315W mutation occurred at the outer helices of the ANK4 and ANK5 domains in the N-terminal cytoplasmic domain. In vitro functional expression studies in HeLa cells showed that the mutant protein formed cytoplasmic aggregates and had reduced surface expression. In cotransfection studies, both mutant and wildtype proteins were detected in cytoplasmic aggregates. Mutant TRPV4 cells showed an impaired response to stimulus-dependent channel activity. The studies indicated that the mutation interferes with normal channel trafficking and function. Haploinsufficiency was proposed as the most likely underlying mechanism, although a gain of function could not be fully excluded. Chen et al. (2010) identified a heterozygous R315W mutation in a 47-year-old mother and her 26-year-old daughter with HMSN2C and vocal cord paresis; the family had originally been reported by Dyck et al. (1994). Both patients had onset in infancy and developed a relatively severe form of distal muscle weakness and distal sensory loss, as well as short stature. Aharoni et al. (2011) reported a 3-generation family of Ashkenazi/Sephardic Jewish origin with variable expression of HMSN2C due to a heterozygous R315W TRPV4 mutation. Five mutation carriers in 1 family were studied. The proband was a girl who presented at birth with inspiratory stridor, clubfeet, congenital hip dislocation, and knee contractures. She had absent reflexes and bilateral vocal cord paresis requiring tracheostomy. In childhood, she showed delayed motor development, progressive distal amyotrophy and weakness, weakness of the shoulder girdle, scoliosis, and pectus excavatum. Neurophysiologic studies showed an axonal sensorimotor neuropathy. Two of her affected brothers also presented with stridor in infancy and showed a similar phenotype, but without electrophysiologic examination. The mother showed a milder phenotype; she reported being unathletic as a child and having a hoarse voice. In her thirties, she developed slowly progressive fatigue associated with mild distal muscle atrophy in the lower limbs. She had poor reflexes and minimal distal temperature sensitivity. Electrophysiologic studies showed a sensorimotor neuropathy. One mutation carrier in this family was clinically unaffected at age 14 years, although deep tendon reflexes were difficult to elicit. (less)
|
|
Pathogenic
(Jan 12, 2024)
|
no assertion criteria provided
Method: clinical testing
|
TRPV4-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004738554.2
First in ClinVar: Mar 16, 2024 Last updated: Oct 08, 2024 |
Comment:
The TRPV4 c.943C>T variant is predicted to result in the amino acid substitution p.Arg315Trp. This variant has been reported in multiple individuals with TRPV4-related autosomal … (more)
The TRPV4 c.943C>T variant is predicted to result in the amino acid substitution p.Arg315Trp. This variant has been reported in multiple individuals with TRPV4-related autosomal dominant conditions, including scapuloperoneal spinal muscular atrophy, and functional studies support its pathogenicity (Auer-Grumbach et al. 2010. PubMed ID: 20037588; Fecto et al. 2011. PubMed ID: 21454511; Inada et al. 2012. PubMed ID: 22702953). It has been reported as a de novo finding, and also to segregate with affected status in families (Faye et al. 2019. PubMed ID: 31191204; Chen et al. 2010. PubMed ID: 21115951; ClinVar Variation ID: 4999). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. (less)
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Neuromuscular disease
Affected status: yes
Allele origin:
germline
|
GeneReviews
Accession: SCV000148064.2
First in ClinVar: Dec 21, 2015 Last updated: Oct 01, 2022 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database. | Tunca C | Human mutation | 2020 | PMID: 32579787 |
Autosomal Dominant TRPV4 Disorders. | Adam MP | - | 2020 | PMID: 24830047 |
Combined Phenotypes of Spondylometaphyseal Dysplasia-Kozlowski Type and Charcot-Marie-Tooth Disease Type 2C Secondary to a TRPV4 Pathogenic Variant. | Faye E | Molecular syndromology | 2019 | PMID: 31191204 |
Homozygous TRPV4 mutation causes congenital distal spinal muscular atrophy and arthrogryposis. | Velilla J | Neurology. Genetics | 2019 | PMID: 31041394 |
Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy. | Echaniz-Laguna A | Neurology | 2014 | PMID: 24789864 |
Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel. | Inada H | Biochemistry | 2012 | PMID: 22702953 |
Striking phenotypic variability in familial TRPV4-axonal neuropathy spectrum disorder. | Aharoni S | American journal of medical genetics. Part A | 2011 | PMID: 22065612 |
Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies. | Fecto F | The Journal of biological chemistry | 2011 | PMID: 21454511 |
CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene. | Chen DH | Neurology | 2010 | PMID: 21115951 |
Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. | Zimoń M | Brain : a journal of neurology | 2010 | PMID: 20460441 |
Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. | Auer-Grumbach M | Nature genetics | 2010 | PMID: 20037588 |
Confirmation of a hereditary motor and sensory neuropathy IIC locus at chromosome 12q23-q24. | McEntagart ME | Annals of neurology | 2005 | PMID: 15668982 |
Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. | Dyck PJ | Annals of neurology | 1994 | PMID: 8179305 |
click to load more click to collapse |
Text-mined citations for rs267607143 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.